Skip to main content
FinSpry Logo
FinSpry
CRSP logo
CRSP
(NASDAQ)
CRISPR Therapeutics AG
$49.51-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

CRISPR Therapeutics (CRSP) Stock Price & Financial Analysis

CRISPR Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$47.10 - $49.95
52-Week High$78.48
52-Week Low$30.04
Open$47.10
Volume1.72M
Average Volume (3M)1.72M
Market Cap4.45B
Shares Outstanding89.93M
Price to Sales (P/S)1676.56
Price to Book (P/B)2.28
EV/EBITDA-6.59
Revenue (TTM)2.62M
Net Income (TTM)-581.60M
Free Cash Flow (TTM)-370.93M
EPS (TTM)$-6.47
Profit Margin-22215.39%
Operating Margin-25384.68%
Return on Equity (ROE)-30.26%
Debt to Equity0.11
50-Day MA$52.04
200-Day MA$56.15
52-Week Change47.28%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About CRISPR Therapeutics

What is the current stock price for CRSP?

As of the latest trading session, CRSP stock trades at $49.51. The 52-week range is $30.04–$78.48, with a day range of $47.10–$49.95.

What is the P/E ratio for CRSP?

The P/E ratio (Price-to-Earnings) for CRSP is shown in the Key Statistics section. This valuation metric helps compare CRISPR Therapeutics AG to industry peers.

Does CRSP pay dividends?

CRISPR Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for CRSP?

Based on 14 analysts, the consensus for CRSP is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of CRSP?

CRISPR Therapeutics's market capitalization is $4.45B, classifying it as a mid-cap company. CRISPR Therapeutics operates in the Healthcare sector within the Biotechnology industry.